Immunocore Holdings plc
IMCR
$30.96
$0.230.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 104.48M | 103.69M | 97.96M | 93.88M | 84.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.48M | 103.69M | 97.96M | 93.88M | 84.05M |
| Cost of Revenue | -184.57M | 71.09M | 70.05M | 831.00K | -153.20M |
| Gross Profit | 289.05M | 32.61M | 27.92M | 93.05M | 237.25M |
| SG&A Expenses | 42.65M | 39.78M | 42.79M | 40.20M | 42.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -19.73M | -- | -- | -- | -18.05M |
| Total Operating Expenses | 104.44M | 110.86M | 112.84M | 97.50M | 85.45M |
| Operating Income | 37.00K | -7.17M | -14.88M | -3.62M | -1.40M |
| Income Before Tax | -15.79M | 304.00K | -9.69M | 6.08M | -24.82M |
| Income Tax Expenses | 14.27M | 481.00K | 606.00K | 1.06M | -1.05M |
| Earnings from Continuing Operations | -30.06M | -177.00K | -10.30M | 5.02M | -23.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.06M | -177.00K | -10.30M | 5.02M | -23.77M |
| EBIT | 37.00K | -7.17M | -14.88M | -3.62M | -1.40M |
| EBITDA | 871.00K | -6.37M | -14.10M | -2.76M | -235.00K |
| EPS Basic | -0.60 | 0.00 | -0.20 | 0.10 | -0.48 |
| Normalized Basic EPS | -0.20 | 0.00 | -0.12 | 0.01 | -0.26 |
| EPS Diluted | -0.60 | 0.00 | -0.20 | 0.10 | -0.48 |
| Normalized Diluted EPS | -0.20 | 0.00 | -0.12 | 0.01 | -0.26 |
| Average Basic Shares Outstanding | 50.47M | 50.40M | 50.29M | 50.09M | 50.05M |
| Average Diluted Shares Outstanding | 50.47M | 50.40M | 50.29M | 51.95M | 50.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |